Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study
J Eur Acad Dermatol Venereol
.
2020 Oct;34(10):e644-e646.
doi: 10.1111/jdv.16511.
Epub 2020 May 25.
Authors
A-C Fougerousse
1
,
P-D Ghislain
2
,
Z Reguiai
3
,
F Maccari
4
,
J Parier
4
,
D Bouilly Auvray
5
,
G Chaby
6
,
V Pallure
7
,
J-L Schmutz
8
,
C Clément
9
,
C Jacobzone
10
,
E Begon
11
,
E Esteve
12
;
GEM ResoPso
Affiliations
1
Dermatology Department, Military Teaching Hospital Bégin, St Mandé, France.
2
Dermatology Department, Private Practice, St-Luc University Hospital, Bruxelles, Mons, Belgium.
3
Dermatology Department, Courlancy Polyclinic, Reims, France.
4
Private Practice, La Varenne, France.
5
Private Practice, Dijon, France.
6
Dermatology Department, University Hospital, Amiens, France.
7
Dermatology Department, Perpignan Hospital, Perpignan, France.
8
Dermatology Department, University Hospital Brabois, Vandoeuvre les Nancy, France.
9
Dermatology Department, University Hospital of Côte de Nacre, Caen, France.
10
Dermatology Department, University Hospital of Lorient, Lorient, France.
11
Dermatology Department, Pontoise Hospital, Pontoise, France.
12
Dermatology Department, Regional Hospital, Orléans, France.
PMID:
32314452
DOI:
10.1111/jdv.16511
No abstract available
Publication types
Letter
Multicenter Study
MeSH terms
Antibodies, Monoclonal, Humanized*
Humans
Psoriasis* / drug therapy
Retrospective Studies
Substances
Antibodies, Monoclonal, Humanized
guselkumab